Lupin logo

LUPIN - Lupin News Story

₹1212.25 14.9  1.2%

Last Trade - 12/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.30bn
Enterprise Value £5.50bn
Revenue £1.47bn
Position in Universe 81st / 3110

BUZZ-India's Lupin drops after U.S. FDA issues warning letter to facility

Thu 19th September, 2019 6:51am
** Shares of drug manufacturer Lupin Ltd  LUPN.NS  fall as
much as 3.3% to an over two-week low of 733.75 rupees
    ** Says U.S. FDA issued warning letter to its Mandideep
facility, without giving details for the action  urn:newsml:reuters.com:*:nFWN26A009
    ** Warning letter comes after FDA in March classified its
inspection at the facility as "Official Action Indicated" -
Lupin 
    ** Says warning letter will not disrupt supplies or existing
revenues from operations of the facility
    ** Stock sees worst session since Aug. 23 and is down 10%
this year, as of last close 


 ((Chandini.M@thomsonreuters.com; 910867497919;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.